These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6782828)

  • 1. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus.
    Monn E
    Acta Paediatr Scand; 1981 Jan; 70(1):39-42. PubMed ID: 6782828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L; Jonkman A; Thomas C
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
    Jakobsson B; Berg U
    Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.
    Libber S; Harrison H; Spector D
    J Pediatr; 1986 Feb; 108(2):305-11. PubMed ID: 3080575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
    Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
    Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
    Vierhapper H; Jörg J; Favre L; Vallotton MB; Waldhäusl W
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of prostaglandin synthesis during the therapy of nephrogenic diabetes insipidus].
    Stögmann W; Bohrn E
    Wien Klin Wochenschr; 1984 Jan; 96(1):12-6. PubMed ID: 6710993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R; Brodehl J
    Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
    Uyeki TM; Barry FL; Rosenthal SM; Mathias RS
    Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of postobstructive polyuria.
    Smoyer WE
    Am J Dis Child; 1991 Dec; 145(12):1345-8. PubMed ID: 1669655
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis.
    Kamperis K; Rittig S; Bower WF; Djurhuus JC
    J Urol; 2012 Nov; 188(5):1915-22. PubMed ID: 22999686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus.
    Smith LG; Kirshon B; Cotton DB
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):98-9. PubMed ID: 2197875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U; Chan JC
    Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hypernatremia due to abnormal thirst mechanism in a 13-year-old child with nephrogenic diabetes insipidus.
    Anand SK; Kogut MD; Lieberman E
    J Pediatr; 1972 Dec; 81(6):1097-105. PubMed ID: 4643027
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V; Koller DY; Seidl R; Waldhauser F
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N; Monnens LA
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract]   [Full Text] [Related]  

  • 19. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of indomethacin in tubular defects.
    Usberti M; Pecoraro C; Federico S; Cianciaruso B; Guida B; Romano A; Grumetto L; Carbonaro L
    Pediatrics; 1985 Mar; 75(3):501-7. PubMed ID: 3856211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.